Ashwagandha

Ashwagandha (Withania somnifera) is a small, evergreen, perennial shrub of the Solanaceae family — the same family that includes tomato, potato, eggplant, chilli pepper and tobacco. It grows to about 35-75 cm in height, with grey-green oval leaves, small bell-shaped greenish-yellow flowers, and orange-red berries about the size of a small cherry. Despite the dramatic-sounding alternative name 'Indian Ginseng', ashwagandha is botanically unrelated to true ginseng (Panax ginseng) — the comparison is functional rather than taxonomic, based on the similar way both plants have been used in their respective herbal traditions as restorative or 'tonic' herbs.

The Sanskrit name 'ashwagandha' translates literally as 'smell of horse', referring on one level to the strong, slightly horse-like smell of the freshly-dug fresh root, and on another level to a traditional Ayurvedic belief that the plant gives the strength and vigour of a horse to those who take it. The Latin species name somnifera means 'sleep-bringing' — a reference to the plant's traditional use in Ayurvedic practice for promoting restful sleep, although in modern Western use the herb is more often associated with daytime adaptogenic effects than with sedation. The same plant supports both uses in the traditional view, depending on dose and preparation.

In the Ayurvedic system of traditional Indian medicine, ashwagandha is classified as a 'rasayana' — a category of herbs and preparations specifically used to support overall vitality, longevity and resilience over time, rather than to address acute illness. The rasayana category includes some of the most prized herbs of the Ayurvedic pharmacopoeia, and ashwagandha has been consistently grouped among the most important of them in Ayurvedic texts going back at least 3,000 years. It is sometimes called 'the king of Ayurvedic herbs' in modern Indian herbal literature — a description that overstates the case slightly (Ayurveda has no formal hierarchy of herbs) but accurately reflects ashwagandha's standing as one of the most extensively used and best-documented plants in the entire Indian medicinal tradition.

Withania somnifera is native to the dry regions of the Indian subcontinent, the Middle East and parts of Africa. Its core native range covers central and northern India, Pakistan, Nepal and Afghanistan, with smaller populations extending westwards through Iran and the Arabian peninsula and southwards into northern and eastern Africa. Within this range, ashwagandha grows in disturbed sandy soils, dry scrubland, fallow fields and along roadsides — it is a hardy, drought-tolerant plant that does best in hot, dry climates with well-drained soils and relatively low rainfall. It is not a tropical rainforest plant; it is a plant of arid and semi-arid zones.

Today, the overwhelming majority of commercial ashwagandha — both for the global supplement market and for traditional Ayurvedic preparations within India — is cultivated in the central and western Indian states of Madhya Pradesh, Rajasthan, Punjab, Gujarat and Haryana. The Madhya Pradesh region in particular has become the centre of organic, certified, traceable ashwagandha cultivation, supplying most of the high-quality standardised extracts on the European supplement market. The most well-known of these is KSM-66, a full-spectrum root extract produced in Madhya Pradesh by a single Indian manufacturer that has dominated the premium ashwagandha extract market for the past decade.

Ashwagandha is not native to Europe and is not commercially cultivated anywhere in Europe at meaningful scale. The European climate is wrong for it — too cool, too damp, too much winter dormancy — and the long Ayurvedic tradition of cultivation in India has produced both the best agronomic knowledge of the plant and the strongest infrastructure for processing the dried root into standardised extract. For European supplement brands, the established practice is therefore to source ashwagandha from a certified organic Indian supplier — typically one of a small number of producers in Madhya Pradesh that operate to international quality standards and provide third-party laboratory testing for active compound content, contaminants and pesticide residues.

Ashwagandha is one of the most extensively documented herbs in the entire history of Ayurvedic medicine, with continuous written records of its use going back at least 3,000 years. The earliest references appear in the foundational texts of Ayurveda — the Charaka Samhita (compiled in approximately the 1st century BC, but containing material that is much older) and the Sushruta Samhita (of similar age). Both texts describe ashwagandha as a primary rasayana herb, indicating that even by the time these texts were written down, the plant was already a well-established part of the Indian medicinal tradition with a long oral history behind it.

Through the medieval period, ashwagandha remained a cornerstone of Ayurvedic practice across the Indian subcontinent. It was prepared in many forms — as a root powder mixed with warm milk and ghee (the most common traditional preparation), as a decoction, as a herbal wine called arishta, and as one of several ingredients in complex multi-herb formulas. The traditional uses described in classical Ayurvedic texts are broad: support for vitality and physical strength, support for restful sleep (the somnifera reference), support for the body's response to stress and exertion, and use as a general restorative for older adults or for people recovering from illness. The Ayurvedic categorisation of ashwagandha as a rasayana places it firmly in the 'long-term wellness' tradition rather than in the 'acute remedy' tradition.

Ashwagandha entered Western herbal practice relatively recently — primarily during the 20th century, as Western interest in Indian and Asian medicinal traditions grew. For most of the 20th century it remained a niche herb known mainly to specialist Western herbalists with an interest in Ayurveda, but in the 2000s and especially the 2010s ashwagandha became one of the fastest-growing botanical ingredients in the global supplement market. This shift was driven by a combination of two things: a growing Western interest in the concept of 'adaptogens' (a category of herbs traditionally used to support the body's response to stress), and the commercial availability of standardised, well-characterised extracts like KSM-66 that gave Western supplement formulators a consistent and reliable raw material to work with. Today, ashwagandha is one of the most widely-used herbal ingredients in European, North American and Asian supplement markets — a remarkable journey for a plant that was almost unknown in Western herbal practice three generations ago.

The active compounds in ashwagandha root are concentrated in a unique class of molecules called withanolides — naturally-occurring steroidal lactones with no exact equivalent in European herbal medicine. Modern phytochemical research has identified more than 35 distinct withanolides in Withania somnifera, with the most pharmacologically studied being withanolide A, withaferin A, withanolide D, and the withanosides (glycosylated forms of the core withanolides, including withanoside IV and withanoside VI). Different parts of the plant contain different relative ratios of these compounds — the root, the leaves and the berries each have characteristic profiles, which is one reason why responsible producers specify exactly which plant part their extract is made from.

Beyond the withanolide complex, ashwagandha root also contains the sitoindosides (a small group of glycowithanolides), trace alkaloids (including isopelletierine and anaferine), free amino acids and a small fixed-oil fraction. The sitoindosides have received attention in modern research as a possibly significant secondary class of bioactive compounds, and some standardised extracts are calibrated to total bioactive content (withanolides plus sitoindosides) rather than to a single marker compound. The relative proportions of all these compounds vary depending on the growing conditions, the age of the plant when harvested, and the method of extraction — which is why standardisation matters for any modern supplemental use.

The most widely-used standardised ashwagandha extract on the global supplement market is KSM-66 — a full-spectrum root extract (no leaf, no chemical solvents) standardised to a minimum of 5% total withanolides by HPLC. KSM-66 is produced in Madhya Pradesh, India, by a single manufacturer using a proprietary extraction process that took 14 years to develop and was first released commercially in 2010. The 'full-spectrum' designation is significant: many cheaper ashwagandha extracts are produced from the leaf rather than the root (because leaves are easier to harvest and have higher absolute withanolide content), but Ayurvedic tradition specifies the root as the medicinal part of the plant, and full-spectrum root extracts preserve the broader range of compounds that distinguishes the traditional preparation from a purified single-compound extract.

In modern supplemental practice, ashwagandha is most commonly used in the form of a standardised root extract in capsules, with daily doses typically ranging from 200mg to 600mg of extract per serving — the higher end corresponding to formulas where ashwagandha is the cornerstone ingredient rather than a token addition. The 600mg/day dose is the one most commonly used in modern clinical research on KSM-66, and supplemental products that follow this research generally provide 300mg per capsule taken twice daily, or 600mg in a single daily serving. Lower doses (around 200-300mg/day) are also widely used, typically in multi-ingredient formulas where ashwagandha is combined with other herbs and micronutrients.

Ashwagandha is generally taken with food. There is no strong evidence-based recommendation for time of day, but two patterns are common in modern practice: some users take it in the morning with breakfast (positioning it as a daytime adaptogen for stress support), and others take it in the evening with dinner (echoing the somnifera traditional use for restful sleep). Both patterns have their advocates, and individual responses vary — the consistent advice across both is that regularity matters more than timing, and the herb is generally taken daily for periods of weeks or months at a time.

As with most traditionally-used herbs, the European Food Safety Authority (EFSA) has not yet issued a specific approved health claim for Withania somnifera. This places ashwagandha in the broad regulatory category of 'traditionally-used' botanical ingredients in EU supplement labelling — the historical use is exceptionally well-documented (over 3,000 years of continuous Ayurvedic practice), and the modern clinical research base on ashwagandha is more developed than for most traditional herbs, but the EFSA approval process for specific health claims has its own evidentiary requirements that ashwagandha has not yet met. Ashwagandha-containing supplement products in Europe typically carry EFSA-approved claims that attach to other ingredients in the formula — most commonly the B-vitamins, magnesium, and zinc that contribute to normal psychological function, the reduction of tiredness, and hormonal balance.

Ashwagandha has a generally good safety profile in the modern supplement literature when used at typical supplemental doses. Adverse effects are uncommon and typically mild — most often mild gastrointestinal effects (nausea, loose stools, stomach discomfort) that resolve when the herb is taken with food or when the dose is reduced. Some users report drowsiness, particularly when taken in the evening at higher doses, which is consistent with the somnifera traditional use. The plant has been used safely in the Ayurvedic tradition for over 3,000 years without significant toxicity concerns at traditional preparation doses.

There are several important contraindications to be aware of. Ashwagandha is not recommended during pregnancy — both Ayurvedic tradition and modern caution advise against its use in pregnancy because of the historical reputation of the plant as an abortifacient (the practical evidence for this is mixed, but the precaution is universally observed). The plant is also generally not recommended during breastfeeding due to insufficient research in this population. People with autoimmune conditions (such as Hashimoto's thyroiditis, lupus, multiple sclerosis or rheumatoid arthritis) should consult their doctor before taking ashwagandha, because the herb may interact with the immune-modulating activity that affects these conditions. People taking thyroid medication should also exercise caution, as ashwagandha can theoretically affect thyroid function.

Drug interactions to consider: ashwagandha may have an additive effect with sedatives, sleep medications and anti-anxiety drugs — combining them can increase drowsiness more than either would alone. It may also interact with thyroid medications (it can either increase or decrease the effects of thyroid hormone replacement therapy depending on the individual), with immunosuppressive drugs (it has immune-modulating activity that can theoretically work against the intended effect of these drugs), and potentially with blood sugar and blood pressure medications. Anyone taking prescription medication should consult their doctor before starting an ashwagandha supplement, especially if they fall into one of these categories.